Jyske Realkredit A/S
24.3.2026 08:56:18 CET | Globenewswire | Press release
Succession at Jyske Realkredit A/S
Succession at Jyske Realkredit A/S
To Nasdaq Copenhagen A/S 24 March 2026
Announcement no. 27/2026
Succession at Jyske Realkredit A/S
After 25 years with Jyske Realkredit, Executive Director Torben Hansen has decided to retire. He will step down from his position effective 1 June 2026.
Torben Hansen began his career in the financial sector in 1979 and joined BRFkredit in 2001 as Head of Credit. BRFkredit later became Jyske Realkredit, where Torben Hansen was appointed to the Executive Management in 2018.
Chief Executive Officer Anders Lund Hansen states:
“Torben has been a highly respected professional at Jyske Realkredit and a valued sparring partner in the Executive Management. He has contributed strong analytical insight and a clear focus on maintaining the right balance between market opportunities and risk. I would like to thank Torben for his commitment and close cooperation and wish him all the very best for the future.”
Following Torben Hansen’s retirement, the Executive Management of Jyske Realkredit will consist of Chief Executive Officer Anders Lund Hansen and Executive Director Lisbeth Arentzen.
Yours sincerely,
Jyske Realkredit
Contact: Anders Lund Hansen, CEO, Jyske Realkredit, tel. +45 89 89 92 20.
Please observe that the Danish version of this announcement prevails.
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Oma Säästöpankki Oyj7.10.2026 20:30:00 CEST | Press release
Notification under Chapter 9, Section 10 of the Securities Market Act: Holdings of S-Bank Plc in Oma Savings Bank Plc has exceeded 90 percent
Oma Säästöpankki Oyj7.10.2026 19:30:00 CEST | Press release
Notification under Chapter 9, Section 10 of the Securities Market Act: Holdings of Parkanon Säästöpankkisäätiö in Oma Savings Bank Plc has fallen below the flagging threshold
Zealand Pharma7.10.2026 19:13:53 CEST | Press release
Zealand Pharma announces positive Phase 2 ZUPREME-2 topline results for amylin analog petrelintide in people with overweight or obesity and type 2 diabetes
ALK Abello7.10.2026 19:01:45 CEST | Press release
ALK upgrades its full-year outlook on strong tablet sales
ALK Abello7.10.2026 19:01:45 CEST | Pressemeddelelse
ALK opjusterer forventningerne til 2026 på baggrund af stærkt tabletsalg
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom